Open access · CC-BY
via OpenAlex
Inflammatory Biomarker Trends Predict Respiratory Decline in COVID-19 Patients
Alisa A. Mueller, Tomoyoshi Tamura, Conor Crowley, Jeremy R. DeGrado, Hibah Haider, Julia L. Jezmir, Gregory Keras, Erin H. Penn, Anthony F. Massaro, Edy Yong Kim
Cell Reports Medicine · 2020 · ▲ 116 citations
Abstract
In this single-center, retrospective cohort analysis of hospitalized coronavirus disease 2019 (COVID-19) patients, we investigate whether inflammatory biomarker levels predict respiratory decline in patients who initially present with stable disease. Examination of C-reactive protein (CRP) trends reveals that a rapid rise in CRP levels precedes respiratory deterioration and intubation, although CRP levels plateau in patients who remain stable. Increasing CRP during the first 48 h of hospitalization is a better predictor (with higher sensitivity) of respiratory decline than initial CRP levels or ROX indices (a physiological score of respiratory function). CRP, the proinflammatory cytokine interleukin-6 (IL-6), and physiological measures of hypoxemic respiratory failure are correlated, which suggests a mechanistic link. Our work shows that rising CRP predicts subsequent respiratory deterioration in COVID-19 and may suggest mechanistic insight and a potential role for targeted immunomodulation in a subset of patients early during hospitalization.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1016/j.xcrm.2020.100144
- Canonical
- link ↗
- Fetched
- 2026-11-13 MST
Cite this
APA
Mueller, A.A., Tamura, T., Crowley, C., DeGrado, J.R., Haider, H., Jezmir, J.L., Keras, G., Penn, E.H., Massaro, A.F., & Kim, E.Y. (2020). Inflammatory Biomarker Trends Predict Respiratory Decline in COVID-19 Patients. <em>Cell Reports Medicine</em>. https://doi.org/10.1016/j.xcrm.2020.100144
Vancouver
Mueller AA, Tamura T, Crowley C, DeGrado JR, Haider H, Jezmir JL, et al. Inflammatory Biomarker Trends Predict Respiratory Decline in COVID-19 Patients. Cell Reports Medicine. 2020. doi:10.1016/j.xcrm.2020.100144.
BibTeX
@article{alisa2020Inflam,
title = {Inflammatory Biomarker Trends Predict Respiratory Decline in COVID-19 Patients},
author = {Alisa A. Mueller and Tomoyoshi Tamura and Conor Crowley and Jeremy R. DeGrado and Hibah Haider and Julia L. Jezmir and Gregory Keras and Erin H. Penn and Anthony F. Massaro and Edy Yong Kim},
journal = {Cell Reports Medicine},
year = {2020},
doi = {10.1016/j.xcrm.2020.100144},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
InTech eBooks 2013
Open access · CC-BY
Time Flies: Autophagy During Ageing in Drosophila
Frontiers in Immunology 2021
Open access · CC-BY
Interleukin-6 Is a Biomarker for the Development of Fatal Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia
University Hospital, Geneva 2020
Open access · US-GOV
COVIDAge Study- Hospital Des Trois-Chêne
Annals of Clinical and Translational Neurology 2022
Open access · CC-BY
Phosphorylated alpha‐synuclein in Iba1‐positive macrophages in the skin of patients with Parkinson's disease
Clinical Laboratory 2023
Citation only
Interleukin-6 (IL-6) as a Predictor of Clinical Outcomes in Patients with COVID-19
Zenodo (CERN European Organization for Nuclear Research) 2022
Preprint · CC-BY